You won ’t fix what you don’t value: Two reasons why traditional cost-effective analyses can perpetuate health inequities

Anew report from Partnership for Health Analytic Research or PHAR describes how value assessments that use traditional cost-effectiveness analyses can overlook important health disparities and risk perpetuating health inequities.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: The Value Collaborative Value Assessment Health Equity Source Type: news